Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

750 results about "Arabinose" patented technology

Arabinose is an aldopentose – a monosaccharide containing five carbon atoms, and including an aldehyde (CHO) functional group. For biosynthetic reasons, most saccharides are almost always more abundant in nature as the "D"-form, or structurally analogous to D-glyceraldehyde. However, L-arabinose is in fact more common than D-arabinose in nature and is found in nature as a component of biopolymers such as hemicellulose and pectin.

Lithocarpus litseifolius modified acidic polysaccharide as well as preparation method and application thereof

The invention provides modified acidic polysaccharide of lithocarpus litseifolius. The modified acidic polysaccharide is prepared from natural acidic polysaccharide of lithocarpus litseifolius through a chemical method or an enzyme method. Every 100 mg of the modified acidic polysaccharide of lithocarpus litseifolius contains 89.75 mg + / -1.04 mg to 90.67 mg + / -1.46 mg of total polysaccharide. The total uronic acid content is 23.70 mg + / -1.58 mg to 71.74 mg + / -2.07 mg; total bound phenol: 2.06 mg of GAE + / -0.06 mg of GAE-4.56 mg of GAE + / -0.04 mg of GAE (equivalent weight of gallic acid); the esterification degree is 3.72% + / -0.90% to 34.98% + / -0.62%; the molecular weight is (0.562 + / -0.012) * 10 < 4 > Da-(4.268 + / -0.055) * 10 < 4 > Da; the proportion of the galacturonic acid glycan (HG) is 15.28% to 65.02%; the ratio of the type I rhamnogalacturonan (RG-I) is 28.47% to 72.37%; and the length of a side chain is 0.44 to 10.31. The invention further provides a preparation method and application of the lithocarpus litseifolius modified acidic polysaccharide. The lithocarpus litseifolius modified acidic polysaccharide prepared by the invention has remarkable immunoregulatory activity, and especially has better immunocompetence when being used for removing arabinose side chains and reducing galactose side chains.
Owner:CHENGDU UNIV

Attenuated salmonella typhimurium EN-VNP strain as well as preparation method and application thereof

PendingCN119932072ABacteriaTransferasesEnzyme GenePhosphotransferase Gene
The invention discloses an attenuated salmonella typhimurium EN-VNP (Enhanced Natriuretic Peptide) strain as well as a preparation method and application of the attenuated salmonella typhimurium EN-VNP strain. Comprising the following steps: on the basis of a salmonella VNP20009 strain, flagellin genes fliC and fljB, a phosphoethanolamine transferase gene eptA, a 4-amino-4-deoxy-L-arabinose transferase gene arnT and phosphotransferase yeiU are sequentially knocked out or silenced, and a strain is formed after a phosphotransferase gene lpxE is knocked in or overexpressed, so that the attenuated salmonella typhimurium EN-VNP strain is prepared. According to the attenuated salmonella typhimurium EN-VNP with low toxicity and the T cell adjuvant effect and an EN-OMV antigen delivery system prepared from the attenuated salmonella typhimurium EN-VNP, an improved strain does not contain flagellin, an LPS molecular structure is changed, the attenuated salmonella typhimurium EN-VNP has the low toxicity and the T cell adjuvant effect, and normal multiplication culture can be achieved.
Owner:JIANGSU TARGET BIOMEDICINE RES INST

Gastrodia elata polysaccharide and application thereof

The invention belongs to the field of new application of medicines, and particularly relates to gastrodia elata polysaccharide and application thereof. The gastrodia elata polysaccharide component GEP-2 is separated from crude gastrodia elata polysaccharide, structural characterization detection is conducted on the GEP-2, the result shows that the gastrodia elata polysaccharide GEP-2 is prepared from, by mass, 89.08% of glucose, 2.40% of galactose, 7.12% of galacturonic acid, 0.86% of arabinose and 0.54% of rhamnose, and the animal experiment result shows that the GEP-2 relieves the symptoms of mouse colitis, relieves weight loss and shortens the colon length; the traditional Chinese medicine composition has the advantages of reducing serum TNF-alpha, IL-1beta and IL-6 proinflammatory cytokine levels, improving the intestinal barrier function, reducing inflammatory cell infiltration, regulating the intestinal flora composition structure of mice and relieving ulcerative colitis.
Owner:CHONGQING ACAD OF CHINESE MATERIA MEDICA +1

An in vitro cell-free protein synthesis system (D2P system), its reagent kit and its applications

This invention provides an in vitro cell-free protein synthesis system, its reagent kit, and its applications, belonging to the field of protein synthesis technology. This invention improves an in vitro cell-free protein synthesis system based on Kluyveromyces lactis by adding exogenous L-arabinose, significantly enhancing the system's protein synthesis capacity. Furthermore, it provides a more efficient and higher-throughput in vitro protein synthesis reagent kit and a method for synthesizing exogenous proteins. The improvements provided by this invention can be achieved without molecular modification, are simple and convenient to operate, and save costs.
Owner:KANGMA (SHANGHAI) BIOTECH LTD

Homogenized pitaya polysaccharide as well as preparation method and application thereof

The invention provides homogenized pitaya polysaccharide as well as a preparation method and application thereof, and belongs to the technical field of polysaccharide extraction and purification. The homogenized pitaya polysaccharide is a polysaccharide of which the monosaccharide is composed of mannose, glucosamine hydrochloride, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose, the relative molecular weight is 8.08 * 10 < 4 > Da, and the corresponding molar ratio is (0.181): (0.250): (16.544): (12.762): (3.793): (0.739): (51.014): (14.716). The invention further provides a preparation method of the homogenized pitaya polysaccharide and application of the homogenized pitaya polysaccharide in preparation of lipid-lowering and sugar-lowering drugs. The homogenized pitaya polysaccharide disclosed by the invention has an obvious lipid-lowering and blood-glucose-reducing effect, is from a natural product, so that the homogenized pitaya polysaccharide has no toxic or side effect and can be used for preparing lipid-lowering and blood-glucose-reducing medicines.
Owner:NANJING UNIV OF FINANCE & ECONOMICS

Application of ganoderma lucidum strain SS30 in preparation of products for treating cancers

The invention discloses application of a ganoderma lucidum strain SS30 in preparation of a product for treating cancers, and belongs to the technical field of biology. The invention provides ganoderma lucidum strain SS30 mycelium polysaccharide. The ganoderma lucidum strain SS30 mycelium polysaccharide is prepared from glucose, galactose, mannose, fucose, xylose, arabinose, rhamnose, glucuronic acid, glucosamine, ribose and lacturonic acid. The polysaccharide has a remarkable effect of inhibiting transplantable pancreatic cancer and primary colorectal cancer, can achieve the effect of treating cancer by improving the immune function and reducing the oxidation product generation level, provides a new material for development and utilization of lucid ganoderma and products thereof, and has a wide application prospect. And a research basis is provided for research and development of cancer-related drugs and research of a cancer treatment mechanism.
Owner:ANHUI SPRY BIOTECHNOLOGY CO LTD +1

Establishment method and application of salvia miltiorrhiza polysaccharide HPLC fingerprint spectrum

The invention relates to the field of establishment of fingerprints of traditional Chinese medicinal materials, in particular to an establishment method and application of a salvia miltiorrhiza polysaccharide HPLC (High Performance Liquid Chromatography) fingerprint. The establishment method comprises the following steps: preparation of a test solution: taking a salvia miltiorrhiza polysaccharide hydrolysis solution, carrying out derivatization in a reaction bottle, and passing through a 0.1-0.3 [mu] m microporous filter membrane; preparing a reference substance solution, namely weighing mannose, ribose, rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose reference substances, and preparing into a mixed reference substance solution; performing HPLC (high performance liquid chromatography) determination; and establishing the salvia miltiorrhiza polysaccharide HPLC fingerprint spectrum. According to the method, the difference of monosaccharide composition and content in salvia miltiorrhiza medicinal materials from different producing areas and the spectrum-effect relationship between antioxidant activity and anticoagulant activity are clarified, and a certain reference basis is provided for quality control and evaluation of the salvia miltiorrhiza medicinal materials from the aspect of polysaccharide.
Owner:SHANGLUO UNIV

Gardenia polysaccharide as well as preparation method and application thereof

The invention relates to gardenia polysaccharide as well as a preparation method and application thereof. The gardenia polysaccharide comprises the following monosaccharide units: rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose, or mainly comprises rhamnose, glucuronic acid, galacturonic acid, glucose, galactose and arabinose; the molar ratio of rhamnose to glucuronic acid to galacturonic acid to glucose to galactose to arabinose in the gardenia polysaccharide is (3-15): (1-8): (4-18): (1-6): (15-35): (25-70). According to the gardenia polysaccharide, FFA induced mouse primary parenchymal hepatic cell lipid accumulation can be reduced, no obvious cytotoxic effect exists, CDAHFD diet induced hepatic fibrosis can be reduced, and the gardenia polysaccharide has a good effect of preventing and / or treating non-alcoholic steatohepatitis.
Owner:SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

Allium macrostemon polysaccharide as well as preparation method and application thereof

The invention provides allium macrostemon polysaccharide as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The method comprises the following steps: extracting and purifying small root garlic to obtain crude polysaccharides, namely AMBP 40, AMBP 60 and AMBP 80; separating to prepare a polysaccharide component AMBP60-1, and then separating to prepare the uniform polysaccharide AMBP-1a of the allium macrostemon. The AMBP-1a is mainly composed of galactose, glucose and arabinose in a molar ratio of 0.836: 0.158: 0.006, and the AMBP-1a is a neutral heteropolysaccharide. The structural characteristics of polysaccharide are related to activity, AMBP-1a can effectively improve the blood fat level of ApoE- / -atherosclerosis model mice, pharmacological activity of atherosclerosis plaques and the like, and atherosclerosis is intervened by regulating intestinal flora and short-chain fatty acid content.
Owner:JINAN UNIVERSITY

Recombinant entomopathogenic bacteria prepared using promoter replacement technique, preparation method, and uses thereof

Proposed are recombinant entomopathogenic bacteria transformed using promoter replacement technique, a preparation method, and uses thereof for producing pesticides and controlling pests. Provided are recombinant entomopathogenic bacteria in which the promoter of the GXP synthase gene (gxpS gene) is replaced in the entomopathogenic bacteria with an arabinose inducible promoter using a promoter replacement technique. The recombinant entomopathogenic bacteria prepared in the present disclosure can produce large quantities of GXPs, which acts to suppress immunity of pests, by controlling the expression of the GXP synthetase gene (gxpS gene) through an addition of an inducer. The recombinant entomopathogenic bacteria prepared in the present disclosure can also effectively control pests through a response that suppresses the immunity of pests.
Owner:IND -ACADEMIC COOP FOUNDATION OF GYEONGKUK NATIONAL UNIVERSITY

System for co-producing L-arabinose and caramel pigment by using xylose chromatography raffinate

The utility model belongs to the technical field of sugar alcohol preparation, and relates to a system for co-producing L-arabinose and caramel pigment by using xylose chromatography raffinate, which comprises a raw material tank, a nanofiltration membrane separator, a chromatography separation device, an evaporation concentration tank, a crystallization tank, a centrifugal separator and a dryer which are sequentially communicated by pipelines, and the browning reaction assembly is used for mixing the raffinate and the centrifugal mother liquor and then carrying out browning reaction treatment to prepare caramel pigment. The chromatographic separation device is used for separating an extracting solution and raffinate from the flowing nanofiltration permeate, the evaporation concentration tank and the crystallizing tank are used for concentrating and crystallizing the flowing extracting solution into massecuite, the centrifugal separator is used for separating the flowing massecuite into moist sugar and centrifugal mother liquor, and the dryer is used for drying the flowing moist sugar into L-arabinose crystals. According to the utility model, raffinate and centrifugal mother liquor are mixed to prepare a caramel pigment liquid product, so that a caramel pigment additional product is obtained while the utilization rate of saccharide resources is improved.
Owner:ZHEJIANG HUAKANG PHARMA

Xanthan oligosaccharides having glp-1 agonist activity and uses thereof

The application provides a Huangdache oligosaccharide with GLP-1 agonist activity and application thereof, and belongs to the technical field of medicines. 3 The oligosaccharide component ELYP-3 has a molecular weight of 3.2*10 3 Da, and the molar ratio of monosaccharides is rhamnose:galacturonic acid:glucose:galactose:arabinose = 1:32.42:45.37:9.11:6.54. The Huangdache oligosaccharide fragment obtained by glycosidase degradation has significant hypoglycemic and weight loss activities, the preparation process is simple, specific and green, and provides scientific basis and theoretical support for the development of natural GLP-1 agonists. Meanwhile, the functional oligosaccharide provides a wide application prospect for the development of medicines with blood glucose regulation.
Owner:ANHUI AGRICULTURAL UNIVERSITY

Method for producing xylitol through two-step enzyme catalysis of hemicellulose hydrolysate

The invention belongs to the technical field of biology, and particularly relates to a method for producing xylitol through two-step enzyme catalysis of hemicellulose hydrolysate, and the method comprises the following steps: taking hemicellulose hydrolysate as a raw material, adding arabinose dehydrogenase, NADH oxidase and coenzyme NADH, and carrying out first-step fermentation until no L-arabinose residue exists in fermentation liquor to obtain fermentation reaction liquor I; and adding xylose reductase and glucose dehydrogenase into the fermentation reaction liquid I, and carrying out second-step fermentation to obtain a fermentation product containing xylitol. According to the two-step enzyme catalysis method provided by the invention, xylitol is prepared, and high-purity xylose does not need to be used as a raw material; according to the present invention, the cheap hemicellulose hydrolysate can be directly adopted as the raw material, the xylose conversion rate and the xylitol yield can exceed 99%, the impurity arabitol content in the product is low, the other impurity saccharic acid is easy to separate, and the problems of complex process, large separation difficulty and high cost in the xylitol refining process are successfully solved.
Owner:ęµ™ę±Ÿå®¹é”ē§‘ęŠ€ęœ‰é™å…¬åø

An active Inonotus obliquus polysaccharide IOP-1 against non-small cell lung cancer and its application

The present invention discloses an anti-non-small cell lung cancer active birch inonotus polysaccharide IOP-1 and its application, belonging to the field of biomedicine. The present invention adopts a method of boiling water extraction and ethanol precipitation of birch inonotus polysaccharide, and combines DEAE cellulose column purification technology, and utilizes the principle that macromolecular polysaccharides are insoluble in organic solvents to successfully achieve the separation of birch inonotus polysaccharide and obtain a birch inonotus polysaccharide IOP-1 with anti-non-small cell lung cancer activity, wherein the monosaccharide composition of the birch inonotus polysaccharide IOP-1 includes fucose, rhamnose, arabinose, galactose, glucose, xylose and mannose with a molar mass ratio of 2.41:0.58:1.03:2.17:82.20:4.33:7.29. Its significant effect against non-small cell lung cancer was verified by in vitro and in vivo experiments, providing a new treatment method for the clinical treatment of non-small cell lung cancer.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Preparation method of avocado soup rich in eucommia seeds

The invention discloses a preparation method of avocado soup rich in eucommia ulmoides seeds, which comprises the following steps: modifying chickpea protein isolate (CPI) through dynamic high-pressure microjet (DHPM), assisting grafting modification of CPI and arabinose (AB) by DHPM, preparing nano-emulsion rich in eucommia ulmoides seed oil by using the modified chickpea protein isolate (CPI) as an emulsifier, and adding the nano-emulsion into the avocado soup to improve the fat-soluble nutrient content of the avocado soup.
Owner:ZHENGZHOU UNIVERSITY OF LIGHT INDUSTRY

Hawthorn heteropolysaccharide as well as preparation method and application thereof

The invention relates to the field of medicines, foods or health-care products, in particular to big-fruit hawthorn heteropolysaccharide as well as a preparation method and application thereof. The large-fruit hawthorn heteropolysaccharide is prepared from galacturonic acid, glucuronic acid, mannose, xylose, arabinose, glucose, galactose, fucose and rhamnose. The weight-average molecular weight of the big fruit hawthorn heteropolysaccharide is 81.6 kDa to 157.3 kDa. The product has unique structures of complex monosaccharide composition, low molecular weight, appropriate uronic acid content, low esterification degree and the like; compared with CP which is single in structure and high in esterification, the CP is better in oxidation resistance and bile acid binding capacity; compared with hawthorn polysaccharide with low uronic acid content and high molecular weight, the hawthorn polysaccharide has the advantages that the enzyme inhibition activity is obviously enhanced, and the hawthorn polysaccharide has a wide prospect in development of functional food, health care products or medicines for regulating blood sugar / blood fat, resisting oxidation and preventing metabolic syndromes.
Owner:GUANGXI ZHUANG AUTONOMOUS REGION ACAD OF AGRI SCI +1

Compositions comprising homogeneous polysaccharides or derivatives thereof and methods for preventing and / or

The present invention provides compositions and methods for improving bone formation, bone mass, and / or strength, and / or treating or preventing bone loss, such as senescent bone loss, in a subject in need of such therapy. The composition comprises a homogeneous polysaccharide, or a pharmaceutically acceptable ester or salt thereof, or a pharmaceutically acceptable solvate thereof, or any combination thereof, and a pharmaceutically acceptable excipient. The homogeneous polysaccharide is mainly composed of arabinose, galactose, rhamnose and galacturonic acid as monomeric units. Such methods comprise administering to a subject in need thereof an effective dose of such a composition.
Owner:INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES +1

Hippophae rhamnoides leaf homogeneous polysaccharide as well as preparation method and application thereof

The invention discloses a hippophae rhamnoides leaf homogeneous polysaccharide as well as a preparation method and application thereof. The method comprises the following steps: drying hippophae rhamnoides leaves, crushing, decolorizing with 85% ethanol, degreasing with petroleum ether, extracting with hot water, centrifugally concentrating, dialyzing with a dialysis bag (8000-14000 Da), precipitating with absolute ethyl alcohol, centrifuging, and freeze-drying in vacuum to prepare crude polysaccharide of the hippophae rhamnoides leaves, further purifying the crude polysaccharide with AB-8 macroporous resin to obtain the hippophae rhamnoides leaf polysaccharide. And carrying out separation and purification by adopting an anion exchange DEAE Sepharose Fast Flow chromatographic column and a Superdex-75 gel column chromatography method, so as to obtain the hippophae rhamnoides leaf homogeneous polysaccharide. The molecular weight of the hippophae rhamnoides leaf homogeneous polysaccharide obtained by the method is 14.18 * 10 < 3 > Da, the hippophae rhamnoides leaf homogeneous polysaccharide is composed of rhamnose, glucuronic acid, galacturonic acid, galactose and arabinose, and the molar ratio of monosaccharides of the hippophae rhamnoides leaf homogeneous polysaccharide is 3.20: 2.63: 83.24: 6.04: 4.81. The hippophae rhamnoides leaf homogeneous polysaccharide prepared by the method disclosed by the invention has immunomodulatory activity, can be used for preparing a medicine for enhancing the immunomodulatory effect, and has better application prospect and market value.
Owner:XINJIANG AGRI UNIV

Fermentation process capable of shortening fermentation period and efficiently synthesizing Ectoine

The invention discloses a fermentation process for efficiently synthesizing Ectoine by shortening a fermentation period, which is characterized in that the fermentation process for producing Ectoine by fermenting engineering escherichia coli taking glucose, xylose and arabinose as a mixed carbon source is adopted, so that the fermentation time is shortened to 40.5 h, the yield of Ectoine can reach 112.2 g / L, the production efficiency of Ectoine reaches 2.77 g / L / h, and the yield of Ectoine is greatly improved. And compared with fermentation production of Ectoin by taking glucose as a carbon source, the efficiency is improved by 132%.
Owner:NANJING TECH UNIV +1

Probiotic composition for promoting ethanol metabolism and probiotic agent and application thereof

The invention provides a probiotic composition for promoting ethanol metabolism as well as a probiotic agent and application thereof, and belongs to the technical field of biological medicines. The preparation method comprises the following steps: compounding lactobacillus mucus A21252, plant lactobacillus A21352, casei paracasei A21151 and lactobacillus reuteri A21325 to obtain a probiotic composition, and matching the probiotic composition with auxiliary materials (resistant dextrin, xylooligosaccharide, erythritol, L-arabinose, lemon fruit powder and corn oligopeptide powder) to obtain the probiotic agent. The probiotic agent not only can quickly improve the hangover alleviating speed, has the effects of alleviating hangover, protecting liver and eliminating gastrointestinal dysfunction caused by alcoholism, but also can reduce discomfort caused by excessive drinking. The probiotic agent is simple and convenient to process, low in cost and wide in market prospect.
Owner:AIAGE LIFE SCI CORP LTD +1

Application of uncaria acidic polysaccharide URP-2 in preparation of anti-esophageal cancer drugs

The invention discloses application of uncaria acidic polysaccharide URP-2 in preparation of an anti-esophageal cancer drug, and belongs to the technical field of antitumor of medicinal plant polysaccharide. According to the method, a method for extracting the uncaria total polysaccharide by boiling water and precipitating the uncaria total polysaccharide by ethanol is adopted, and a DEAE DE-52 cellulose column and sephadex column purification technology is combined, so that the separation of the uncaria acidic polysaccharide component is realized, and the uncaria acidic polysaccharide URP-2 is obtained. The uncaria acidic polysaccharide URP-2 comprises the following components in mole percent: 14.11% of arabinose, 12.64% of rhamnose, 6.48% of galactose, 5.00% of glucose and 61.77% of galacturonic acid. Experiments show that the uncaria acidic polysaccharide URP-2 has remarkable anti-esophageal cancer activity, so that a potential experimental basis and a new strategy are provided for applying the uncaria acidic polysaccharide URP-2 to clinical treatment of esophageal cancer.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Composition for reducing blood pressure, blood sugar and blood fat

The invention discloses a composition for reducing blood pressure, blood sugar and blood fat, and belongs to the technical field of food processing. The moringa oleifera health-care food is prepared from moringa oleifera leaf powder, mulberry leaf powder, wall-broken ganoderma lucidum spore powder, passion fruit powder, prune powder, sea buckthorn powder, roxburgh rose powder, acerola cherry powder, angelica keiskei powder, corn stigma extract, perfume lemon powder, cyclocarya paliurus extract, radix puerariae extract, globe artichoke extract, lecithin, enzymes, OMEGA-3, arabinose and fructo-oligosaccharide. The plant composition which is sour with sweetness and good in taste is prepared by compounding and seasoning all edible raw materials such as glucosyl stevioside / hesperidin, the plant composition has good effects of reducing blood pressure, blood sugar and blood fat, and the adopted raw materials are healthy, non-toxic, easy to obtain, non-toxic to human bodies, especially livers, suitable for popular use and good in application prospect.
Owner:JIANGNAN UNIV

Barley-roasted malt polysaccharide with anti-cancer effect as well as preparation method and application of barley-roasted malt polysaccharide

The invention discloses a preparation method and application of roasted barley and malt polysaccharide with an anti-cancer effect. The roasted barley malt polysaccharide is a neutral heteropolysaccharide which mainly takes-> 3)-beta-D-Glcp-(1-> and->-beta-D-Glcp-(1->) as main chains, branches exist at O-3 / O-4 positions, and the branch chains are mainly composed of-> 4)-beta-D-Xylp-(1->,-> 3, 4)-beta-D-Xylp-(1-> and alpha-D-Glcp-(1->. The monosaccharide composition comprises arabinose, glucose and xylose in a molar mass ratio of 1.86: 33.43: 1.00, and the molecular weight is 23.81 kDa. In-vitro activity experiments prove that the roasted barley malt polysaccharide disclosed by the invention has a remarkable inhibition effect on proliferation of liver cancer cells, lung cancer cells, breast cancer cells and colorectal cancer cells, particularly on the liver cancer cells, and shows outstanding anti-tumor activity, so that the roasted barley malt polysaccharide is expected to be developed and applied in the fields of foods, health-care products or medicines.
Owner:SHANGHAI JIAOTONG UNIV +1

Multi-product preparation method based on arabinoxylan-lignin compound

The invention relates to the technical field of plant extraction, in particular to a multi-product preparation method based on an arabinoxylan-lignin compound. The method comprises the following steps: treating a lignocellulose raw material by adopting a weak base extracting solution and a strong base extracting solution, and separating an obtained strong base extracting and dealkalizing suspension into an arabinoxylan-lignin compound dispersion liquid and arabinoxylan; performing enzymolysis on the dispersion liquid, and filtering enzymatic hydrolysate to obtain a precipitate which is lignin and a filtrate which is xylooligosaccharide liquid; and separating and purifying the xylooligosaccharide liquid to obtain xylooligosaccharide, xylose and arabinose. According to the method, on the basis of a weak base-strong base two-step extraction process, obtained arabinoxylan-lignin compound dispersion liquid is subjected to enzymolysis, so that lignin, xylooligosaccharide, xylose and arabinose can be continuously prepared, and the reutilization of the arabinoxylan-lignin compound is realized.
Owner:GUANGXI INST OF BOTANY THE CHINESE ACAD OF SCI

Active inonotus obliquus polysaccharide IOP-1 for resisting non-small cell lung cancer and application of inonotus obliquus polysaccharide IOP-1

The invention discloses inonotus obliquus polysaccharide IOP-1 capable of resisting non-small cell lung cancer activity and application, and belongs to the field of biological medicine. The method for extracting the inonotus obliquus polysaccharide by boiling water and precipitating the inonotus obliquus polysaccharide by ethanol is combined with a DEAE (diethylaminoethanol) cellulose column purification technology, and the principle that macromolecular polysaccharide is insoluble in an organic solvent is utilized, so that the separation of the inonotus obliquus polysaccharide is successfully realized, and the inonotus obliquus polysaccharide IOP-1 with non-small cell lung cancer resisting activity is obtained. The monosaccharide of the inonotus obliquus polysaccharide IOP-1 comprises fucose, rhamnose, arabinose, galactose, glucose, xylose and mannose, wherein the molar mass ratio of the fucose to the rhamnose to the arabinose to the galactose to the glucose to the xylose to the mannose is 2.41: 0.58: 1.03: 2.17: 82.20: 4.33: 7.29. In-vivo and in-vitro experiments prove that the traditional Chinese medicine composition has a remarkable effect of resisting the non-small cell lung cancer, and a novel treatment method is provided for clinical treatment of the non-small cell lung cancer.
Owner:CHANGCHUN UNIV OF CHINESE MEDICINE

Composition for regulating body weight through satiety-sugar control dual-channel, and preparation method and application thereof

The invention discloses a composition for regulating body weight through satiety-sugar control double channels. The composition is prepared from the following components in parts by weight: 5-25 parts of cinnamon extract, 1-20 parts of ganoderma lucidum EGCG composite powder, 10-40 parts of L-arabinose, 5-40 parts of composite fruit and vegetable fiber powder, 5-25 parts of fructus cannabis protein peptide, 1-20 parts of apple polyphenol, 1-20 parts of white kidney bean dietary fiber powder and 1-20 parts of agaricus bisporus powder. The composition is characterized in that digestion and absorption of carbohydrate are inhibited, the swelling ratio larger than or equal to 35 times is achieved through a composite fiber system, gastric emptying is remarkably prolonged, satiety hormones such as GLP-1 are adjusted, and the composition can be used as a non-alternative weight management product and is good in safety.
Owner:GUANGDONG YUEWEI BIOLOGICAL TECH CO LTD +1

Alsophila spinulosa polysaccharide compound, extraction method and application thereof

The invention discloses a polysaccharide compound of Alsophila spinulosa and an extraction method and application thereof, wherein the polysaccharide compound is composed of rhamnose, arabinose, galactose and glucuronic acid. The polysaccharide compound of the invention is derived from mature leaves of Alsophila spinulosa, and is extracted by water extraction and alcohol precipitation, crude polysaccharide impurity removal, DEAE seplife FF ion column separation, and Sephacryl S‑400HR gel column purification. The method is simple and fast to operate, and water extraction and anhydrous ethanol precipitation are mainly used in the extraction and separation process. The process method is environmentally friendly, and the purity of the compound separated by the method is relatively high, all greater than 92%. The extracted polysaccharide compound has been found to have a significant hypoglycemic effect through research, and can be used as a raw material for new drug development and pharmacological activity research, and can also be used for food additives or health care product development.
Owner:SICHUAN AGRI UNIV +1

Leiocassis longirostris intestinal health functional additive based on spermaceti soxhlet metabolite

The invention relates to the technical field of aquaculture, in particular to a leiocassis longirostris intestinal health functional additive based on spermaceti soxhlet metabolite. The Leiocassis longirostris intestinal health functional additive comprises the following functional components: chondroitin sulfate, N-acetyl-D-galactosamine, 4 ', 4', 4 ', 4', 4 ', 4', 4 ', 4', 4 ', 4', 4 ', 4'- The composition is prepared from the following raw materials: 4, 6-dihydroxyflavone, polydatin, ascorbic acid, glucoside, arabinogalactan, 3-O-beta-D-galactopyranosyl-L-arabinose, tyramine, 4A-hydroxytetrahydrobiopterin, hyaluronic acid and 3-mercapto-2-butanol. According to the technical scheme, the technical problem that an existing probiotic viable bacterium preparation is difficult to meet the intestinal health management requirement in intensive culture of the leiocassis longirostris can be solved. Compared with the prior art, the scheme is more efficient, stable and safe, healthy development of the Leiocassis longirostris breeding industry can be effectively promoted, and the method has ideal application and popularization prospects.
Owner:FISHERIES INST SICHUAN ACADEMY OF AGRI SCI

Allium fistulosum bolete polysaccharide as well as preparation method and application thereof

The invention discloses allium fistulosum and bolete polysaccharide as well as a preparation method and application thereof. The allium fistulosum and bolete polysaccharide is a glycopolymer composed of arabinose, xylose, mannose, glucose and galactose. The allium fistulosum bolete polysaccharide disclosed by the invention has strong antioxidant capacity, has a stimulation and activation effect on macrophage immune response, has an inhibition effect on alpha-glucosidase, has the effects of resisting oxidation, enhancing immunity and reducing blood sugar, and can be applied to development of health-care foods and functional foods.
Owner:SOUTH CHINA UNIV OF TECH

Application of portulaca oleracea polysaccharide in preparation of medicine for treating psoriasis

The invention firstly discloses application of portulaca oleracea polysaccharide in preparation of the medicine for treating psoriasis, the medicine for treating psoriasis can improve psoriasis-like skin injury and reduce skin tissue inflammation, and the portulaca oleracea polysaccharide is single-component pure polysaccharide extracted from portulaca oleracea and purified. The monosaccharide composition is composed of all or several monosaccharides of rhamnose, arabinose, galactose, glucose, xylose and galacturonic acid, and the molecular weight of the monosaccharide composition is 80-200 kDa. The invention further discloses application of the purslane polysaccharide in preparation of drugs for treating psoriasis and application of the purslane polysaccharide in preparation of cosmetics and medical auxiliary materials for relieving psoriasis-like skin injury. The purslane polysaccharide disclosed by the invention is high in purity, clear in structure and high in safety, has a good psoriasis treatment effect, is superior to dexamethasone in curative effect, can be used as a skin external medicine, a cosmetic, a medical instrument and a medical auxiliary material, and has various potential application values.
Owner:SUZHOU UNIV